Avantax Planning Partners, Inc. Nuvasive Inc Transaction History

Avantax Planning Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$47.64 - $71.26 $122,958 - $183,922	-2,581 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$52.03 - $71.41 $134,289 - $184,309	2,581 New	2,581 $183,000
Q2 2018 Aug 13, 2018	SELL	$48.15 - $56.68 $125,478 - $147,708	-2,606 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$46.03 - $61.28 $119,954 - $159,695	2,606 New	2,606 $136,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.